These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 19946789)
41. Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals. Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Martín-Gandul C; López-Medrano F; de Gopegui ER; Ramón Blanco J; García-Pardo G; Calbo E; Horcajada JP; Granados A; Jover-Sáenz A; Dueñas C; Pujol M; Clin Microbiol Infect; 2014 Apr; 20(4):361-7. PubMed ID: 23991832 [TBL] [Abstract][Full Text] [Related]
42. Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method. Wang JL; Wang JT; Sheng WH; Chen YC; Chang SC BMC Infect Dis; 2010 Jun; 10():159. PubMed ID: 20529302 [TBL] [Abstract][Full Text] [Related]
43. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355 [TBL] [Abstract][Full Text] [Related]
44. High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus. San-Juan R; Fernández-Ruiz M; Gasch O; Camoez M; López-Medrano F; Domínguez MÁ; Almirante B; Padilla B; Pujol M; Aguado JM; J Antimicrob Chemother; 2017 Jul; 72(7):2102-2109. PubMed ID: 28379553 [TBL] [Abstract][Full Text] [Related]
45. [A multicentric study on clinical characteristics and antibiotic sensitivity in children with methicillin-resistant Wu X; Yu H; He LY; Wang CQ; Xu HM; Zhao RQ; Jing CM; Chen YH; Chen J; Deng JK; Shi J; Lin AW; Li L; Deng HL; Cai HJ; Chen YP; Wen ZW; Yang JH; Zhang T; Xiao FF; Cao Q; Huang WC; Hao JH; Zhang CH; Huang YY; Ji XF Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):628-634. PubMed ID: 32842382 [No Abstract] [Full Text] [Related]
46. Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia? de Sanctis JT; Swami A; Sawarynski K; Gerasymchuk L; Powell K; Robinson-Dunn B; Carpenter CF; Sims MD Diagn Mol Pathol; 2011 Sep; 20(3):184-8. PubMed ID: 21817905 [TBL] [Abstract][Full Text] [Related]
47. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Moore CL; Osaki-Kiyan P; Haque NZ; Perri MB; Donabedian S; Zervos MJ Clin Infect Dis; 2012 Jan; 54(1):51-8. PubMed ID: 22109947 [TBL] [Abstract][Full Text] [Related]
48. Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy. Peel TN; Buising KL; Dowsey MM; Aboltins CA; Daffy JR; Stanley PA; Choong PF Antimicrob Agents Chemother; 2013 Jan; 57(1):350-5. PubMed ID: 23114758 [TBL] [Abstract][Full Text] [Related]
49. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan. Naimi HM; Rasekh H; Noori AZ; Bahaduri MA BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146 [TBL] [Abstract][Full Text] [Related]
50. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan. Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Ozmen Capin BB; Tekeli A; Karahan ZC Microb Drug Resist; 2020 Mar; 26(3):238-244. PubMed ID: 31545160 [No Abstract] [Full Text] [Related]
53. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis. Sipahi OR; Bardak-Ozcem S; Turhan T; Arda B; Ruksen M; Pullukcu H; Aydemir S; Dalbasti T; Yurtseven T; Sipahi H; Zileli M; Ulusoy S Surg Infect (Larchmt); 2013 Aug; 14(4):357-62. PubMed ID: 23672240 [TBL] [Abstract][Full Text] [Related]
54. Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia. Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chang SC; Hsueh PR J Antimicrob Chemother; 2014 Jan; 69(1):211-8. PubMed ID: 23997017 [TBL] [Abstract][Full Text] [Related]
55. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides. Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434 [TBL] [Abstract][Full Text] [Related]
56. Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia. Haque NZ; Zuniga LC; Peyrani P; Reyes K; Lamerato L; Moore CL; Patel S; Allen M; Peterson E; Wiemken T; Cano E; Mangino JE; Kett DH; Ramirez JA; Zervos MJ; Chest; 2010 Dec; 138(6):1356-62. PubMed ID: 20558550 [TBL] [Abstract][Full Text] [Related]
57. Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital. Vaudaux P; Huggler E; Arhin FF; Moeck G; Renzoni A; Lew DP Int J Antimicrob Agents; 2009 Dec; 34(6):540-3. PubMed ID: 19744838 [TBL] [Abstract][Full Text] [Related]
58. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. van Hal SJ; Lodise TP; Paterson DL Clin Infect Dis; 2012 Mar; 54(6):755-71. PubMed ID: 22302374 [TBL] [Abstract][Full Text] [Related]
59. Validation of a treatment algorithm for orthopaedic implant-related infections with device-retention-results from a prospective observational cohort study. Tschudin-Sutter S; Frei R; Dangel M; Jakob M; Balmelli C; Schaefer DJ; Weisser M; Elzi L; Battegay M; Widmer AF Clin Microbiol Infect; 2016 May; 22(5):457.e1-9. PubMed ID: 26806134 [TBL] [Abstract][Full Text] [Related]
60. Phenotypic changes of methicillin-resistant Staphylococcus aureus during vancomycin therapy for persistent bacteraemia and related clinical outcome. Kim T; Kim ES; Park SY; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Chong YP; Kim YS Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1473-1481. PubMed ID: 28337607 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]